Purified inactivated rabies vaccine - Verorab® — Competitive Intelligence Brief

Purified inactivated rabies vaccine - Verorab® (Purified inactivated rabies vaccine - Verorab®) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Inactivated viral vaccine. Area: Immunology / Infectious Disease.

phase 3 Inactivated viral vaccine Immunology / Infectious Disease Biologic

Target snapshot

Purified inactivated rabies vaccine - Verorab® (Purified inactivated rabies vaccine - Verorab®) — Sanofi Pasteur, a Sanofi Company. Verorab stimulates the immune system to produce antibodies and cellular immunity against rabies virus by presenting inactivated viral antigens.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Purified inactivated rabies vaccine - Verorab® TARGET	Purified inactivated rabies vaccine - Verorab®	Sanofi Pasteur, a Sanofi Company	phase 3	Inactivated viral vaccine
HepA-I	HepA-I	Sinovac Biotech Co., Ltd	marketed	Inactivated viral vaccine	Hepatitis A virus (HAV)
Havrix 720 Junior	Havrix 720 Junior	Chiang Mai University	marketed	Inactivated viral vaccine	Hepatitis A virus surface antigen
Sabin IPV	Sabin IPV	Centers for Disease Control and Prevention, China	marketed	inactivated viral vaccine	poliovirus serotypes 1, 2, and 3
SARS-CoV-2 Inactivated Vaccine	SARS-CoV-2 Inactivated Vaccine	PT Bio Farma	marketed	Inactivated viral vaccine
fIPV (0.2mL) IM	fIPV (0.2mL) IM	Centers for Disease Control and Prevention	marketed	Inactivated viral vaccine
IPV-Al	IPV-Al	AJ Vaccines A/S	marketed	Inactivated viral vaccine	Poliovirus serotypes 1, 2, and 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Inactivated viral vaccine class)

1. Sinovac Biotech Co., Ltd · 9 drugs in this class
2. Sanofi Pasteur, a Sanofi Company · 9 drugs in this class
3. GlaxoSmithKline · 5 drugs in this class
4. Valneva Austria GmbH · 4 drugs in this class
5. Medical University of Vienna · 3 drugs in this class
6. Centers for Disease Control and Prevention · 3 drugs in this class
7. China National Biotec Group Company Limited · 2 drugs in this class
8. Statens Serum Institut · 2 drugs in this class
9. Institute of Medical Biology, Chinese Academy of Medical Sciences · 2 drugs in this class
10. Crucell Holland BV · 2 drugs in this class